RecruitingPhase 2NCT05762536
Docetaxel or Cabazitaxel With or Without Darolutamide in mCRPC
Studying Multiple endocrine neoplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Erasmus Medical Center
- Intervention
- Darolutamide(drug)
- Enrollment
- 245 enrolled
- Eligibility
- 18 years · MALE
- Timeline
- 2023 – 2028
Study locations (1)
- Erasmus MC Cancer Institute, Rotterdam, Netherlands
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05762536 on ClinicalTrials.govOther trials for Multiple endocrine neoplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07521436Awareness of Risk Factors and Perception of Cardiovascular Risk in Secondary Prevention Among Women and MenIstituti Clinici Scientifici Maugeri SpA
- RECRUITINGEARLY PHASE1NCT06888102A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate CancerEdwin Posadas, MD
- RECRUITINGNANCT07499167BRAHMS: Bed Rest And HypoMetabolism StudyCentre National d'Etudes Spatiales
- RECRUITINGPHASE1NCT07304128A Study of PLB-002 in Advanced Solid TumorsPrimelink BioTherapeitics(ShenZhen) Limited
- ACTIVE NOT RECRUITINGNCT07518212OST and MORES in Male OsteoporosisKayseri City Hospital
- RECRUITINGNANCT07187518Clinical Study to Estimate Bone Mineral Density With the POROUS Ultrasound DevicePOROUS GmbH
- RECRUITINGPHASE4NCT07397403The Efficacy of Doxycycline Post Exposure Prophylaxis for Preventing STIs Among MSM in Bangkok, Thailand.Bangrak STIs Center
- RECRUITINGNANCT07217834Effects of a Glycerol-Electrolyte Beverage on Fluid Balance in Healthy Euhydrated Men and WomenPepsiCo Global R&D